VKTX Viking Therapeutics, Inc.

Nasdaq vikingtherapeutics.com


$ 33.58 $ -1.20 (-3.44 %)    

Friday, 17-Oct-2025 19:50:30 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 33.535
$ 32.76
$ 33.00 x 2
$ 35.00 x 1,100
$ 32.76 - $ 34.89
$ 18.92 - $ 81.73
4,043,584
na
3.77B
$ 1.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-23-2025 06-30-2025 10-Q
2 04-24-2025 03-31-2025 10-Q
3 02-26-2025 01-01-1970 10-K
4 10-23-2024 09-30-2024 10-Q
5 07-24-2024 06-30-2024 10-Q
6 04-25-2024 03-31-2024 10-Q
7 02-07-2024 12-31-2023 10-K
8 10-25-2023 09-30-2023 10-Q
9 07-26-2023 06-30-2023 10-Q
10 04-26-2023 03-31-2023 10-Q
11 02-10-2023 12-31-2022 10-K
12 10-26-2022 09-30-2022 10-Q
13 07-27-2022 06-30-2022 10-Q
14 04-27-2022 03-31-2022 10-Q
15 02-09-2022 12-31-2021 10-K
16 11-03-2021 09-30-2021 10-Q
17 07-28-2021 06-30-2021 10-Q
18 04-28-2021 03-31-2021 10-Q
19 02-17-2021 12-31-2020 10-K
20 10-28-2020 09-30-2020 10-Q
21 07-29-2020 06-30-2020 10-Q
22 04-30-2020 03-31-2020 10-Q
23 02-26-2020 12-31-2019 10-K
24 11-05-2019 09-30-2019 10-Q
25 08-01-2019 06-30-2019 10-Q
26 05-02-2019 03-31-2019 10-Q
27 03-13-2019 12-31-2018 10-K
28 11-07-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
30 05-09-2018 03-31-2018 10-Q
31 03-07-2018 12-31-2017 10-K
32 11-08-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-21-2017 12-31-2016 10-K
36 11-10-2016 09-30-2016 10-Q
37 08-11-2016 06-30-2016 10-Q
38 05-10-2016 03-31-2016 10-Q
39 03-08-2016 12-31-2015 10-K
40 11-05-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-viking-therapeutics-maintains-102-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Viking Therapeutics (NASDAQ: VKTX) with a Buy and maintains $102...

 btig-reiterates-buy-on-viking-therapeutics-maintains-125-price-target

BTIG analyst Justin Zelin reiterates Viking Therapeutics (NASDAQ:VKTX) with a Buy and maintains $125 price target.

Core News & Articles

https://www.fda.gov/news-events/press-announcements/fda-launches-green-list-protect-americans-illegal-imported-glp-1-drug-ingre...

 jim-cramer-expects-palantir-to-reach-new-all-time-high

Market analysts and financial commentators provide crucial guidance in the volatile investment landscape. Cramer says no to VKT...

 benzinga-bulls-and-bears-sunrun-newegg-walmart--and-powell-offers-rate-cut-hope

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our t...

 vikings-42-plunge-splits-expertsa-129-strong-buy-or-clearly-inferior-drug

Viking (VKTX) stock plunged 42% after its obesity pill trial. Experts are split: some call it a $129 Strong Buy, others say it&...

 palantir-amd-oracle-viking-and-nvidia-why-these-5-stocks-are-on-investors-radars-today

U.S. stock indices closed mixed on Tuesday, with the Dow Jones Industrial Average edging up 0.02% to 44,922.27.

 viking-obesity-pill-faces-steep-climb-against-lillys-tirzepatide-analyst-calls-downtrend-reaction-extreme

Viking shares fell on Phase 2 obesity pill data as tolerability issues surfaced, but William Blair says the stock's sell-of...

 tech-stocks-drop-palantir-plunges-over-8-whats-moving-markets-tuesday

Tech stocks pulled back on Tuesday as the absence of fresh bullish catalysts prompted investors to take profits after the recen...

 hc-wainwright--co-reiterates-buy-on-viking-therapeutics-maintains-102-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Viking Therapeutics (NASDAQ:VKTX) with a Buy and maintains $102 ...

 like-eli-lilly-viking-therapeutics-oral-weight-loss-drug-disappoints-stock-tanks

Viking Therapeutics reported positive Phase 2 results for VK2735, showing significant weight loss and safety in obesity patient...

Core News & Articles

INTCNVDAGOOGLVKTXUNHPLTRBULLRBLXCRWVAMDData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment 

 stock-market-today-sp-500-nasdaq-100-slip-but-dow-futures-riseintel-palo-alto-home-depot-in-focus-updated

U.S. stock futures were fluctuating on Tuesday following mostly unchanged moves from Monday. Futures of major benchmark indices...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION